Differential adipose tissue remodeling and metabolic effects of dolutegravir and bictegravir: implications for HIV therapy
{{output}}
Combined antiretroviral therapy (cART) has significantly improved the prognosis of people with HIV (PWH), but long-term metabolic side effects-particularly weight gain and adipose tissue dysfunction-remain an important concern. Among the components of cART, in... ...
